Clinical Trial Update: Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating KBP-5074 for uncontrolled hypertension in patients with chronic kidney disease has been terminated; no efficacy or safety results are…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• KBP-5074 (KBP-5074)

Snippet

Sponsor: KBP Biosciences | Conditions: Chronic Kidney Diseases | Phase 3 | Status: TERMINATED